These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12106636)

  • 1. Animal models of the cardiovascular effects of exogenous hormones.
    Karas RH
    Am J Cardiol; 2002 Jul; 90(1A):22F-25F. PubMed ID: 12106636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogens, progestins, and coronary artery reactivity in atherosclerotic monkeys.
    Williams JK; Delansorne R; Paris J
    J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):219-24. PubMed ID: 9699876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogens, progestins, and coronary heart disease in cynomolgus monkeys.
    Clarkson TB
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):147S-151S. PubMed ID: 7958009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of estrogen on the cardiovascular system.
    Mendelsohn ME
    Am J Cardiol; 2002 Jun; 89(12A):12E-17E; discussion 17E-18E. PubMed ID: 12084397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression.
    Clarkson TB
    Menopause; 2018 Nov; 25(11):1262-1274. PubMed ID: 30358722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogens, progestins, selective estrogen receptor modulators, and the arterial tree.
    Wild RA; Reis SE
    Am J Obstet Gynecol; 2001 Apr; 184(5):1031-9. PubMed ID: 11303216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic and vascular effect of progestins in post-menopausal women. Implications for cardioprotection.
    Rosano GM; Vitale C; Silvestri A; Fini M
    Maturitas; 2003 Dec; 46 Suppl 1():S17-29. PubMed ID: 14670642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologic and pharmacologic effects of estrogen and progestins on bone.
    DeCherney A
    J Reprod Med; 1993 Dec; 38(12 Suppl):1007-14. PubMed ID: 8120857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestogens and cardiovascular disease. A critical review.
    Clarkson TB
    J Reprod Med; 1999 Feb; 44(2 Suppl):180-4. PubMed ID: 11392029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vascular protection with estrogen. In-vitro and in-vivo effects--mechanisms and clinical implication].
    Barton M; Wright E; Dai-Do D; Yang Z; Espinosa E; Arnet U; Lüscher TF
    Praxis (Bern 1994); 1997 Jan; 86(5):129-37. PubMed ID: 9064730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and nongenomic effects of estrogen in the vasculature.
    Mendelsohn ME
    Am J Cardiol; 2002 Jul; 90(1A):3F-6F. PubMed ID: 12106632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of progestins in different hormone replacement therapy formulations on estrogen-induced lipid changes in postmenopausal women.
    Shulman LP
    Am J Cardiol; 2002 Jun; 89(12A):47E-54E; discussion 54E-55E. PubMed ID: 12084405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of the vascular actions of estrogens in experimental and human studies: why protective early, and not when delayed?
    Lenfant F; Trémollières F; Gourdy P; Arnal JF
    Maturitas; 2011 Feb; 68(2):165-73. PubMed ID: 21167666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular pharmacology of hormone replacement therapy.
    Rosano GM; Panina G
    Drugs Aging; 1999 Sep; 15(3):219-34. PubMed ID: 10503814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogens and Coronary Artery Disease: New Clinical Perspectives.
    Meyer MR; Barton M
    Adv Pharmacol; 2016; 77():307-60. PubMed ID: 27451102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of estrogen in the cardiovascular system].
    Finking G; Gohar MH; Lenz C; Hanke H
    Z Kardiol; 2000 May; 89(5):442-53. PubMed ID: 10900675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease in women: implications of hormone replacement therapy.
    Sarrel PM
    Int J Fertil Menopausal Stud; 1996; 41(2):90-3. PubMed ID: 8829704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endogenous and exogenous estrogens].
    Bejan-Angoulvant T; Arnal JF
    Presse Med; 2019 Nov; 48(11 Pt 1):1244-1248. PubMed ID: 31732361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.
    Psaty BM; Heckbert SR; Atkins D; Siscovick DS; Koepsell TD; Wahl PW; Longstreth WT; Weiss NS; Wagner EH; Prentice R
    Arch Intern Med; 1993 Jun; 153(12):1421-7. PubMed ID: 8512434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.